Viral Hepatitis

Viral hepatitis, a major global health concern, encompasses a group of infectious diseases caused by hepatitis viruses, including hepatitis A, B, C, D, and E. Among these, hepatitis B and C are particularly significant due to their chronic nature and potential to cause severe liver damage, including cirrhosis and liver cancer. Hepatitis B virus (HBV) and hepatitis C virus (HCV) are transmitted through blood and bodily fluids, with risk factors including unsafe injection practices, inadequate sterilization of medical equipment, and unprotected sexual contact. Despite the availability of vaccines for hepatitis A and B, the burden of viral hepatitis remains substantial, with millions of people worldwide affected by chronic infection and its associated complications. Timely diagnosis and treatment are essential for managing viral hepatitis, with molecular diagnostics playing a crucial role in detecting viral RNA or antigens, monitoring disease progression, and assessing treatment response. Furthermore, public health interventions such as vaccination, blood safety measures, and harm reduction strategies are integral to preventing new infections and reducing the global burden of viral hepatitis.